endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Ei­sai, Mer­ck stave off gener­ic com­pe­ti­tion to block­buster can­cer drug Lenvi­ma

3 days ago
Pharma
Law

Large phar­ma com­pa­nies spell out rea­sons why tar­iffs will harm US in­vest­ments 

3 days ago
Pharma
Manufacturing

Taysha’s piv­otal tri­al plans; Keros to stop work on PAH drug, lay off 45% of staff

3 days ago
News Briefing

In­tel­lia re­ports case of liv­er tox­i­c­i­ty in AT­TR gene edit­ing study

3 days ago
R&D

Sanofi’s vac­cine tech trans­fer in Viet­nam; Al­mac’s £1B+ rev­enue mile­stone

3 days ago
Manufacturing

DNA gi­ant Il­lu­mi­na spawned an ecosys­tem of com­peti­tors and cus­tomers

3 days ago
Startups
In Focus

Mer­ck, Dai­ichi Sankyo scrap FDA ap­pli­ca­tion for HER3 ADC af­ter sur­vival miss

3 days ago
R&D
Pharma

FDA re­jects Stealth's rare dis­ease drug, but of­fers po­ten­tial for ac­cel­er­at­ed ap­proval

3 days ago
FDA+
Manufacturing

Oric locks down cash for Phase 3 prostate can­cer tri­al with ear­ly da­ta in hand

3 days ago
R&D

Pep­Gen ditch­es Duchenne pro­grams af­ter mid-stage fail, switch­es to pre­vi­ous­ly halt­ed mus­cle wast­ing ther­a­py

3 days ago
R&D

Ex­clu­sive: Move­ment dis­or­der biotech Vi­ma steps on­to scene with $60M

3 days ago
Financing
Startups

Up­dat­ed: Trump ad­min­is­tra­tion halts more than $750M in funds for Mod­er­na’s bird flu vac­cine

4 days ago
Pharma
Coronavirus

The fate of Mod­er­na’s next-gen Covid shot looms large af­ter a flur­ry of pol­i­cy changes

4 days ago
R&D
FDA+

No­vo Nordisk ‘strong­ly’ urges against phar­ma tar­iffs as com­ments flood in

4 days ago
Pharma
Manufacturing

In­sur­ance start­up De­vot­ed Health cuts 5% of work­ers in small lay­off

4 days ago
People
Startups

GSK, Spero re­port Phase 3 win for UTI an­tibi­ot­ic; Sper­o's stock soars

4 days ago
R&D

Weeks af­ter TIG­IT fail, iTeos de­cides to wind down

4 days ago
People
Startups

Veru’s obe­si­ty drug rough­ly as safe as We­govy; Keros’ board fight

4 days ago
News Briefing

A new dawn for psy­che­delics? Com­pass could be the first to find out

4 days ago
Pharma
In Focus

Post-Hoc Live: Is biotech sen­ti­ment re­al­ly as bad as it seems? 

4 days ago
Financing
Deals

Strand Ther­a­peu­tics re­ports promis­ing start for mR­NA can­cer ther­a­py

4 days ago
R&D

Up­dat­ed: MD An­der­son-al­lied in­vest­ment firm tar­gets $250M for sec­ond can­cer biotech fund

4 days ago
Financing
Startups

In­flaRx cans Go­hibic de­vel­op­ment af­ter skin dis­ease tri­al stopped for fu­til­i­ty

4 days ago
R&D

Ax­some and Het­ero set­tle patent fight over sleep dis­or­der drug

5 days ago
Pharma
Law
First page Previous page 12345 Next page Last page
A service from the Financial Times